Morgan Stanley upgraded Teleflex to Overweight from Equal Weight with a $261 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TFX:
- Teleflex enrolls first patient in MANTA Vascular Closure Device registry
- Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry
- Teleflex’s UroLift shows positive patient experience results in published study
- Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments
- Teleflex to Present at the 35th Annual Piper Sandler Healthcare Conference